Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,634 | 17,772 | 17,347 | 21,659 | 6,478 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,543 |
| Receivables | 5,206 | 5,590 | 10,842 | 4,025 | 1,446 |
| Inventories | 6,809 | 7,084 | 5,974 | 10,606 | 1,930 |
| Other current assets | 3,802 | 2,202 | 1,421 | 8,987 | 337 |
| TOTAL | $40,452 | $32,648 | $35,584 | $45,277 | $11,735 |
| Non-Current Assets | |||||
| PPE Net | 2,539 | 2,596 | 2,901 | 3,594 | 3,304 |
| Intangibles | 60,264 | 75,345 | 83,754 | 92,682 | 8,040 |
| Other Non-Current Assets | 735 | 2,703 | 667 | 13,972 | 0 |
| TOTAL | $63,538 | $80,644 | $87,322 | $110,248 | $11,344 |
| Total Assets | $103,990 | $113,293 | $122,905 | $155,525 | $23,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,846 | 9,210 | 13,855 | 5,262 | N/A |
| Accounts payable and accrued liabilities | 9,168 | 6,206 | 7,293 | 16,183 | 2,418 |
| Other current liabilities | 1,085 | 296 | 280 | 315 | 256 |
| TOTAL | $20,099 | $16,241 | $21,435 | $21,823 | $2,674 |
| Non-Current Liabilities | |||||
| Long Term Debt | 66,521 | 68,200 | 79,122 | 90,563 | N/A |
| Other Non-Current Liabilities | 24,305 | 13,428 | 3,968 | 26,933 | 1,004 |
| TOTAL | $92,981 | $81,852 | $83,315 | $117,727 | $1,004 |
| Total Liabilities | $113,080 | $98,092 | $104,750 | $139,551 | $3,677 |
| Shareholders' Equity | |||||
| Common Shares | 147,423 | 137,926 | 139,238 | 142,545 | 142,914 |
| Retained earnings | -169,791 | -134,812 | -133,011 | -138,764 | -134,900 |
| Other shareholders' equity | 206 | 28 | -47 | 285 | -1 |
| TOTAL | $-9,091 | $15,200 | $18,156 | $15,975 | $19,402 |
| Total Liabilities And Equity | $103,990 | $113,293 | $122,905 | $155,525 | $23,079 |